← All organizations

Pardes Biosciences, Inc.

For profit

Also known as: Pardes Biosciences, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 21, 2022

Acquired by Foresight Biotherapeutics → Shire → Takeda on Jul 17, 2023

Timeline

2010s

Dec 3, 2018
Takeda— Now

2020s

Jun 1, 2020
Pardes Biosciences, Inc.— Founded
Jul 17, 2023
Foresight Biotherapeutics— Acquired By

Drugs by trial phase (3 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Pomotrelvir

Phase 1 (2 own, 0 via acquisition)

Recent trials (2)

NCT05543707Lead sponsorPhase 2Sep 21, 2022
NCT05011812Lead sponsorPhase 1Aug 14, 2021

Details

Founded: Berkeley, CA, US Jun 1, 2020
Last known activity: Sep 21, 2022